Yuan-Yuan Mi (Yuanyuan Mi)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Histone Deacetylase

Prostate Cancer

Top Venues

Cell death & disease

OncoTargets and therapy

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

This page only lists publications with an associated author ORCID identifier.

Publications

Hangsheng Zhou, Jiandong Gui, Lijie Zhu, Yuan-Yuan Mi
The Role and Mechanism of the Histone Methyltransferase G9a in Tumors: Update. OncoTargets and therapy 17 (2024)
Hangsheng Zhou, Jiandong Gui, Lijie Zhu, Yuan-Yuan Mi
The Role and Mechanism of the Histone Methyltransferase G9a in Tumors: Update. OncoTargets and therapy 17 (2024)
Lifeng Zhang, Xiaokai Shi, Lei Zhang, Yuan-Yuan Mi, Li Zuo, Shenglin Gao
A first-in-class TIMM44 blocker inhibits bladder cancer cell growth. Cell death & disease 15 (3) (2024)
Lifeng Zhang, Xiaokai Shi, Lei Zhang, Yuan-Yuan Mi, Li Zuo, Shenglin Gao
A first-in-class TIMM44 blocker inhibits bladder cancer cell growth. Cell death & disease 15 (3) (2024)
Lifeng Zhang, Xiaokai Shi, Lei Zhang, Yuan-Yuan Mi, Li Zuo, Shenglin Gao
A first-in-class TIMM44 blocker inhibits bladder cancer cell growth. Cell death & disease 15 (3) (2024)
Yuan-Yuan Mi, Yu Ji, Lifeng Zhang, Chuan-Yu Sun, Bing-Bing Wei, Dong-Jie Yang, Hong-Yuan Wan, Xiao-Wei Qi, Sheng Wu, Li-Jie Zhu
A first-in-class HBO1 inhibitor WM-3835 inhibits castration-resistant prostate cancer cell growth in vitro and in vivo. Cell death & disease 14 (1) (2023)
Yuan-Yuan Mi, Yu Ji, Lifeng Zhang, Chuan-Yu Sun, Bing-Bing Wei, Dong-Jie Yang, Hong-Yuan Wan, Xiao-Wei Qi, Sheng Wu, Li-Jie Zhu
A first-in-class HBO1 inhibitor WM-3835 inhibits castration-resistant prostate cancer cell growth in vitro and in vivo. Cell death & disease 14 (1) (2023)
Yuan-Yuan Mi, Yu Ji, Lifeng Zhang, Chuan-Yu Sun, Bing-Bing Wei, Dong-Jie Yang, Hong-Yuan Wan, Xiao-Wei Qi, Sheng Wu, Li-Jie Zhu
A first-in-class HBO1 inhibitor WM-3835 inhibits castration-resistant prostate cancer cell growth in vitro and in vivo. Cell death & disease 14 (1) (2023)
Yuan-Yuan Mi, Yu Ji, Lifeng Zhang, Chuan-Yu Sun, Bing-Bing Wei, Dong-Jie Yang, Hong-Yuan Wan, Xiao-Wei Qi, Sheng Wu, Li-Jie Zhu
A first-in-class HBO1 inhibitor WM-3835 inhibits castration-resistant prostate cancer cell growth in vitro and in vivo. Cell death & disease 14 (1) (2023)
Hangsheng Zhou, Hongyuan Wan, Yanyan Feng, Lijie Zhu, Yuan-Yuan Mi
The diagnostic role and mechanistic functions of exosomal lncRNAs in prostate cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2022)